港股创新药概念股持续走低，再鼎医药(09688.HK)、先声药业(02096.HK)跌超7%，绿叶制药(02186.HK)、云顶新耀(01952.HK)跌超6%，石药集团(01093.HK)跌5.9%。

Group 1 - The Hong Kong stock market for innovative drug concept stocks continues to decline, with notable drops in several companies [1] - Zai Lab (09688.HK) and Innovent Biologics (02096.HK) both fell over 7% [1] - Other companies such as Luye Pharma (02186.HK) and Genscript Biotech (01952.HK) experienced declines of over 6%, while CSPC Pharmaceutical Group (01093.HK) dropped by 5.9% [1]